Skip to main content
. 2021 Sep 13;9(9):1206. doi: 10.3390/biomedicines9091206

Figure 3.

Figure 3

Adhesion formation, scored 0–7, Min/Med/Max, time line. Therapy regimens starting at the day 14 after fistula creation (therapy day 0), included BPC 157 given once daily intraperitoneally, last application at 24 h before sacrifice, 10 µg/kg (light gray bars) or 10 ng/kg (dark gray bars) or given perorally, in drinking water 10 µg/kg/day (dashed light gray bars) or 10 ng/kg (dashed dark gray bars) until the sacrifice. Controls received simultaneously an equal volume of saline (5 mL/kg) intraperitoneally (white bars) or drinking water (12 mL/rat/day) (black bars). * p < 0.05, relative to control.